New MS Study Shows TYSABRI Improves Cognitive Impairment

JULY 13TH, 2015  PATRICIA SILVA, PHD



Researchers at Spedali Civili of Brescia in Italy recently published findings in the journalPLoS One that Biogen’s Tysabri (natalizumab) can improve cognitive impairment in patients with relapsing remitting multiple sclerosis (RRMS) over the course of at least three years. The study is entitled “Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.”

Continue